Amy L. Babcock, MPH, DABT®, ERT, MRSB, Joins Bergeson & Campbell, P.C. and The Acta Group
Share Article
Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce that Amy L. Babcock, MPH, DABT®, ERT, MRSB has joined our firms as Senior Scientist. WASHINGTON (PRWEB) May 19, 2021 Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce that Amy L. Babcock, MPH, DABT®, ERT, MRSB has joined our firms as Senior Scientist. Ms. Babcock has 15-plus years of experience leading qualitative and quantitative human health risk assessments in industry and agency roles, most recently as Supervisory Toxicologist and Branch Chief of the U.S. Environmental Protection Agency’s (EPA) Office of Chemical Safety and Pollution Prevention (OCSPP), Office of Pesticide Programs (OPP) in Research Triangle Park, North Carolina. Ms. Babcock will offer clients technical excellence a
Thursday, January 28, 2021
TM. Lawsuits alleging injuries related to pesticide exposure, such as the lawsuits involving Roundup
TM, are not new, and they are ongoing. Plaintiffs in these lawsuits have alleged a variety of health concerns, including skin irritation, respiratory problems, neurological and developmental problems in children (including autism) and cancers. Due to potential health concerns about pesticide exposure, the Environmental Protection Agency requires agricultural establishments (“owners”) to provide workers with information about pesticide and other chemical exposures. Workers are entitled to:
The safety data sheet (SDS),
The name, EPA registration number and active ingredients in the pesticides,
A description of the crop or site treated,
Saturday, December 19, 2020
On December 10, 2020, the U.S. Environmental Protection Agency (EPA) announced a new policy that will allow registrants of antimicrobial pesticide products voluntarily to disclose all inert ingredients more efficiently in response to the request of retailers, states, and industry.
Registrants who wish to disclose all inert ingredient can choose to do so in three ways under the new policy:
On the product label as part of the full ingredient statement or on the product’s back or side panel with a referral to the full ingredient statement;
On a website referenced on the product label; or
On a website that is not directly linked to the product label.